News Desk — April 16, 2018 at 8:12 am — Updated: April 16, 2018 at 8:12 am

Shire sells cancer drugs to Servier for $2.4 billion as Takeda circles


LONDON (Reuters) – Shire , the London-listed rare diseases specialist that is a potential takeover target for Japan’s Takeda Pharmaceutical , is selling its oncology business to unlisted French drugmaker Servier for $2.4 billion (£1.7 billion).

Leave A Comment Using Facebook (Website Comment Form Below)

Use the form below to post a comment via facebook

Leave a Reply

69 queries in 2.014 seconds.